Molecule Ventures LP — Form D/A
Molecule Ventures LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2022-12-15. $243.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-12-15
- Form: D/A
- Accession: 0001812786-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Amount sold: $243.0M
- Minimum investment: $100K
- Investors: 96
- Date of first sale: 2020-05-29
- Security types: fund interests
- SEC file number: 021-368496
Issuer
- Name: Molecule Ventures LP
- CIK: 0001812786
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 860 BROADWAY FL 6, NEW YORK, NY, 10003
- Phone: 929-448-8031
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Nicholas Kracov | Director | New York, NY |
| Nicholas Kracov | Related Person | New York, NY |
| Gary Claar | Director | New York, NY |
| Gary Claar | Related Person | New York, NY |
| Nikhil Mittal | Director | New York, NY |
| Nikhil Mittal | Related Person | New York, NY |
Other filings by this issuer (7)
More